Deciphera Pharmaceuticals Inc (NASDAQ:DCPH)
| 8.29 BATS BZX Real-Time Price As of 10:39am ET |  +0.14 / +1.72%Today’s Change | 7.63 Today|||52-Week Range 52.43 | -15.15% Year-to-Date |
Latest DCPH News | Press Releases
No recent news for Deciphera Pharmaceuticals Inc.
Today’s Trading
| Previous close | 8.15 |
| Today’s open | 8.24 |
| Day’s range | 8.13 - 8.35 |
| Volume | 6,281 |
| Average volume (3 months) | 1,888,900 |
| Market cap | $518.1M |
Data as of 10:39am ET, 01/21/2022
Growth & Valuation
| Earnings growth (last year) | -6.53% |
| Earnings growth (this year) | -4.22% |
| Earnings growth (next 5 years) | +21.00% |
| Revenue growth (last year) | +68.35% |
| P/E ratio | NM |
| Price/Sales | 75.64 |
| Price/Book | 0.94 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VBIVVBI Vaccines Inc | -0.03 | -1.63% |
| ACETAdicet Bio Inc | -0.17 | -1.34% |
| BLUEbluebird bio Inc | -0.11 | -1.52% |
| BTAIBioXcel Therapeutics... | -0.22 | -1.26% |
Data as of 10:40am ET, 01/21/2022
Financials
| Next reporting date | March 16, 2022 |
| EPS forecast (this quarter) | -$1.33 |
| Annual revenue (last year) | $42.1M |
| Annual profit (last year) | -$266.5M |
| Net profit margin | -633.19% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
